跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REBIF 22 interferon beta-1a (rch) 22 microgram/0.5mL injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
REBIF 22 interferon beta-1a (rch) 22 microgram/0.5mL injection pre-filled syringe
Approved
STANDARD
REBIF 22 interferon beta-1a (rch) 22 microgram/0.5mL injection pre-filled syringe
Merck Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
bc728cc3a691e939
Company
Merck Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
bc728cc3a691e939
Product Name
REBIF 22 interferon beta-1a (rch) 22 microgram/0.5mL injection pre-filled syringe
Artg Id
133809
Artg Name
REBIF interferon beta-1a (rch) 22 microgram/0.5mL injection pre-filled syringe
Sponsor
Merck Healthcare Pty Ltd
Company Detail Path
/organization/merck-healthcare-pty-ltd
Artg Date
2008-12-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
bc728cc3a691e939
Type
Standard
Back to TGA Approvals